View in EDS

Interpreting the RAPIDO trial: factors to consider - Authors' reply.

Saved in:
Bibliographic Details
Title: Interpreting the RAPIDO trial: factors to consider - Authors' reply.
Authors: Bahadoer RR; Department of Surgery, Leiden University Medical Center, Leiden, Netherlands., Dijkstra EA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands., van Etten B; Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands., Marijnen CAM; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Putter H; Department of Biomedical Datasciences, Leiden University Medical Center, Leiden, Netherlands., Kranenbarg EM; Department of Surgery, Leiden University Medical Center, Leiden, Netherlands., Nilsson PJ; Department of Surgery, Karolinska University Hospital, Stockholm, Sweden., Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., van de Velde CJH; Department of Surgery, Leiden University Medical Center, Leiden, Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands. Electronic address: g.a.p.hospers@umcg.nl.
Source: The Lancet. Oncology [Lancet Oncol] 2021 Mar; Vol. 22 (3), pp. e90-e91.
Publication Type: Letter; Comment
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33662297
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Interpreting the RAPIDO trial: factors to consider - Authors' reply.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bahadoer+RR%22">Bahadoer RR</searchLink>; Department of Surgery, Leiden University Medical Center, Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Dijkstra+EA%22">Dijkstra EA</searchLink>; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Etten+B%22">van Etten B</searchLink>; Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands.<br /><searchLink fieldCode="AU" term="%22Marijnen+CAM%22">Marijnen CAM</searchLink>; Department of Radiation Oncology, Leiden University Medical Center, Leiden, Netherlands; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Putter+H%22">Putter H</searchLink>; Department of Biomedical Datasciences, Leiden University Medical Center, Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Kranenbarg+EM%22">Kranenbarg EM</searchLink>; Department of Surgery, Leiden University Medical Center, Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Nilsson+PJ%22">Nilsson PJ</searchLink>; Department of Surgery, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Glimelius+B%22">Glimelius B</searchLink>; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22van+de+Velde+CJH%22">van de Velde CJH</searchLink>; Department of Surgery, Leiden University Medical Center, Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Hospers+GAP%22">Hospers GAP</searchLink>; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, Netherlands. Electronic address: g.a.p.hospers@umcg.nl.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100957246%22">The Lancet. Oncology</searchLink> [Lancet Oncol] 2021 Mar; Vol. 22 (3), pp. e90-e91.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter; Comment
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lancet+Pub%2E+Group%22">Lancet Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100957246 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-5488 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214702045%22">14702045 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33662297
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1470-2045(21)00087-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e90
    Titles:
      – TitleFull: Interpreting the RAPIDO trial: factors to consider - Authors' reply.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bahadoer RR
      – PersonEntity:
          Name:
            NameFull: Dijkstra EA
      – PersonEntity:
          Name:
            NameFull: van Etten B
      – PersonEntity:
          Name:
            NameFull: Marijnen CAM
      – PersonEntity:
          Name:
            NameFull: Putter H
      – PersonEntity:
          Name:
            NameFull: Kranenbarg EM
      – PersonEntity:
          Name:
            NameFull: Nilsson PJ
      – PersonEntity:
          Name:
            NameFull: Glimelius B
      – PersonEntity:
          Name:
            NameFull: van de Velde CJH
      – PersonEntity:
          Name:
            NameFull: Hospers GAP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2021 Mar
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1474-5488
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: The Lancet. Oncology
              Type: main
ResultId 1